[1] GOMES FV, GRACE AA. Adolescent stress as a driving factor for schizophrenia development-A basic science perspective[J]. Schizophr Bull, 2017, 43(3): 486. doi: 10.1093/schbul/sbx033
[2] MOLLON J, REICHENBERG A. Cognitive development prior to onset of psychosis[J]. Psychol Med, 2018, 48(3): 392. doi: 10.1017/S0033291717001970
[3] SEIDMAN LJ, MIRSKY AF. Evolving notions of schizophrenia as a developmental neurocognitive disorder[J]. J Int Neuropsychol Soc, 2017, 23(9/10): 881.
[4] 郝蕊, 刘寰忠, 夏磊, 等. 儿童青少年首发精神分裂症认知障碍特征[J]. 安徽医科大学学报, 2018, 53(7): 1118.
[5] NUECHTERLEIN KH, SUBOTNIK KL, VENTURA J, et al. The puzzle of schizophrenia: tracking the core role of cognitive deficits[J]. Dev Psychopathol, 2012, 24(2): 529. doi: 10.1017/S0954579412000132
[6] KESHAVAN MS, MEHTA UM, PADMANABHAN JL, et al. Dysplasticity, metaplasticity, and schizophrenia: implications for risk, illness, and novel interventions[J]. Dev Psychopathol, 2015, 27(2): 615. doi: 10.1017/S095457941500019X
[7] DARK F, NEWMAN E, GORE-JONES V, et al. Randomised controlled trial of compensatory cognitive training and a computerised cognitive remediation programme[J]. Trials, 2020, 21(1): 810. doi: 10.1186/s13063-020-04743-y
[8] MAHMOOD Z, CLARK JMR, TWAMLEY EW. Compensatory Cognitive Training for psychosis: effects on negative symptom subdomains[J]. Schizophr Res, 2019, 204: 397. doi: 10.1016/j.schres.2018.09.024
[9] 张英, 曾剑飞, 王冰, 等. 三种非典型抗精神病药对儿童青少年精神分裂症患者血脂、肝功能和认知功能的影响[J]. 现代生物医学进展, 2021, 21(7): 1328.
[10] 周秀娟, 赖根祥. 药物自我管理技能训练对精神分裂症患者治疗依从性的影响[J]. 中国乡村医药, 2017, 24(15): 66.
[11] 朱晓丹. 急性期精神分裂症患者认知功能影响因素分析及干预研究[D]. 济南: 山东大学, 2020.
[12] 翁永振. 精神分裂症康复操作手册(第二版)[M]. 北京: 人民卫生出版社, 2016.
[13] KAY SR, FISZBEIN A, OPLER LA. The positive and negative syndrome scale (PANSS) for schizophrenia[J]. Schizophr Bull, 1987, 13(2): 261. doi: 10.1093/schbul/13.2.261
[14] 司天梅, 杨建中, 舒良, 等. 阳性和阴性症状量表(PANSS, 中文版)的信、效度研究[J]. 中国心理卫生杂志, 2004, 18(1): 45.
[15] FOLSTEIN MF, FOLSTEIN SE, MCHUGH PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician[J]. J Psychiatr Res, 1975, 12(3): 189. doi: 10.1016/0022-3956(75)90026-6
[16] MORISKY DE, GREEN LW, LEVINE DM. Concurrent and predictive validity of a self-reported measure of medication adherence[J]. Med Care, 1986, 24(1): 67. doi: 10.1097/00005650-198601000-00007
[17] 寸金芝, 赵丽琴. Morisky问卷评价精神分裂症恢复期患者服药依从性的信度和效度[J]. 临床精神医学杂志, 2016, 26(3): 185.
[18] FUSAR-POLIi P, PAPANASTASIOU E, STAHL D, et al. Treatments of negative symptoms in schizophrenia: meta-analysis of 168 randomized placebo-controlled trials[J]. Schizophr Bull, 2015, 41(4): 892. doi: 10.1093/schbul/sbu170
[19] CELLA M, PRETI A, EDWARDS C, et al. Cognitive remediation for negative symptoms of schizophrenia: a network meta-analysis[J]. Clin Psychol Rev, 2017, 52: 43. doi: 10.1016/j.cpr.2016.11.009
[20] VENTURA J, SUBOTNIK KL, GRETCHEN-DOORLY D, et al. Cognitive remediation can improve negative symptoms and social functioning in first-episode schizophrenia: a randomized controlled trial[J]. Schizophr Res, 2019, 203: 24. doi: 10.1016/j.schres.2017.10.005
[21] 李丹丹. 药物自我管理训练对精神分裂症患者的护理分析[J]. 中国医药指南, 2021, 19(25): 196.
[22] 周秀娟, 赖根祥. 药物自我管理技能训练对精神分裂症患者治疗依从性的影响[J]. 中国乡村医药, 2017, 24(15): 66.